QMS Medical Allied Services signs 5-year exclusive distribution deal with HEINE Optotechnik for India

QMS Medical Allied Services Limited has entered into a five-year exclusive agreement with HEINE Optotechnik, a global leader in primary diagnostic instruments. This partnership, effective from January 1, 2027, grants QMS the sole marketing and distribution rights for HEINE's extensive range of diagnostic instruments across India.

The agreement was signed on August 27, 2026, at HEINE's headquarters in Germany. Allan Dabreo, General Manager, Hospital & Distribution Division, represented QMS, while Time Martin, Chief Operations Officer, represented HEINE.

HEINE's net revenues from India in calendar year 2026 were approximately 2.6 million Euros (approximately ₹30 crore). The company anticipates this turnover to increase to ₹70 crore by 2031 as a result of this collaboration. The product portfolio covered under the contract includes a wide array of instruments such as General Medicine and ENT-Instruments, Dermatoscopes, Ophthalmic Instruments, Laryngoscopes, Loupes, Headlights, Veterinary Diagnostic Instruments, and related accessories.

Mahesh Makhija, Chairman & Managing Director of QMS Medical Allied Services Limited, expressed enthusiasm about the partnership, stating it is central to the company's product business expansion strategy and is expected to accelerate growth over the next five years. He also noted that this collaboration will allow QMS to leverage its extensive presence and established reputation in the growing Indian healthcare market.

QMS Medical Allied Services Limited, an integrated healthcare solutions company, has set an ambitious target of surpassing ₹500 crore in revenue by FY29, driven by its product vertical and services portfolio. The company serves over 10 lakh patients and partners with more than 50 leading pharmaceutical and healthcare companies in India.